Gastrointestinal Cancer Clinical Trials & Research at Providence Medical Group
Providence Medical Group is currently enrolling patients for the following
gastrointestinal cancer clinical trials:
Gastric Cancer
Colorectal Cancer
Tucatinib Plus Trastuzumab in Patients with HER2+ Colorectal Cancer
Treatment agent: Tucatinib + Trastuzumab
PI: Ian Anderson, MD
Study Coordinator: Teresa Lund //
Teresa.Lund@stjoe.org // (707) 521-3803 ext. 1103
Resources and Links:
https://clinicaltrials.gov/ct2/show/NCT03043313